Generally, D/E should be less than one as it lends financial stability. But there are capital intensive industries like infra, capital goods wherein D/E ratio remains at a higher level compared with the companies that operate in the FMCG and IT space which are like cash-generating machines.

Specialty pharmaceutical company, Unichem Laboratories informed the bourses that United States Food and Drug Administration (USFDA) has conducted a routine GMP surveillance at company’s Goa formulation facility. The company had submitted ANDAs from this facility.

India-based subsidiary of Dr. Reddy's, Aurigene has entered an exclusive collaboration agreement with the US-based oncology-focused biotech company Exelixis, Inc.

Overall volumes in futures & options currently stand at 2,27,94,937 contracts with a turnover of Rs. 15,25,426.99 crore.

Overall volumes in futures & options currently stand at 2,27,94,937 contracts with a turnover of Rs. 15,25,426.99 crore.

Dilip Buildcon has received the letter of acceptance (LoA) from the Ministry of Road Transport & Highways, New Delhi for a new EPC project in the state of Karnataka.

ZEE Entertainment Enterprise (ZEEL) on Wednesday announced the much-awaited stake sale deal. The Invesco Oppenheimer Developing Markets Fund has agreed to buy 11 per cent stake in ZEEL. 

Due to coal crunch, NTPC has shut down three of its units at its plant located in Kaniha in the state of Orissa.

Dewan Housing Finance Corporation Ltd (DHFL) has completed divestment of its stake in DHFL Pramerica Asset Managers and DHFL Pramerica Trustees to PGLH of Delaware Inc.

As long as Nifty trades below the 200-DMA, there are chances of the index moving further down towards the 10,980 level. Going ahead, only faster retracement above the 200-DMA will boost the sentiments in the markets. Stocks in news: Sun Pharmaceutical, BOSCH, ZEEL, Unichem Laboratories, GMR Infrastructure, Mindtree.